MEDIVIR buy and hold TP1 1600% TP2 2500%Hello friends, investors and those who want to become investors. MEDIVIR, here too a recommendation from the pharmaceutical sector. Buy and enjoy. This stock is definitely a position to hold.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.13 SEK
−89.32 M SEK
7.63 M SEK
77.07 M
About MEDIVIR AB
Sector
CEO
Jens Lindberg
Headquarters
Huddinge
Website
Founded
1987
ISIN
SE0020181014
FIGI
BBG000HPVJQ1
Medivir AB engages in the development of pharmaceuticals products. The firm focuses on the discovery and development of transformative active cancer drugs. Its portfolio includes proprietary pipelines such as remetinostat, birinapant, MV-818, MV-828, and MIV-711 projects, and partnership pipeline which covers xerclear and MIV-802 project. The company was founded in 1988 and is headquartered in Huddinge, Sweden.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MVIR is 2.79 SEK — it has increased by 1.09% in the past 24 hours. Watch MEDIVIR AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange MEDIVIR AB stocks are traded under the ticker MVIR.
MVIR stock has risen by 4.10% compared to the previous week, the month change is a 3.33% rise, over the last year MEDIVIR AB has showed a −10.27% decrease.
We've gathered analysts' opinions on MEDIVIR AB future price: according to them, MVIR price has a max estimate of 54.00 SEK and a min estimate of 10.89 SEK. Watch MVIR chart and read a more detailed MEDIVIR AB stock forecast: see what analysts think of MEDIVIR AB and suggest that you do with its stocks.
MVIR reached its all-time high on Mar 9, 2000 with the price of 161.46 SEK, and its all-time low was 2.33 SEK and was reached on May 23, 2024. View more price dynamics on MVIR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MVIR stock is 4.81% volatile and has beta coefficient of 0.75. Track MEDIVIR AB stock price on the chart and check out the list of the most volatile stocks — is MEDIVIR AB there?
Today MEDIVIR AB has the market capitalization of 312.63 M, it has increased by 4.07% over the last week.
Yes, you can track MEDIVIR AB financials in yearly and quarterly reports right on TradingView.
MEDIVIR AB is going to release the next earnings report on Feb 18, 2025. Keep track of upcoming events with our Earnings Calendar.
MVIR earnings for the last quarter are −0.31 SEK per share, whereas the estimation was −0.34 SEK resulting in a 7.70% surprise. The estimated earnings for the next quarter are −0.32 SEK per share. See more details about MEDIVIR AB earnings.
MEDIVIR AB revenue for the last quarter amounts to 1.20 M SEK, despite the estimated figure of 1.58 M SEK. In the next quarter, revenue is expected to reach 1.85 M SEK.
MVIR net income for the last quarter is −34.60 M SEK, while the quarter before that showed −36.00 M SEK of net income which accounts for 3.89% change. Track more MEDIVIR AB financial stats to get the full picture.
No, MVIR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 10.00 employees. See our rating of the largest employees — is MEDIVIR AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIVIR AB EBITDA is −118.50 M SEK, and current EBITDA margin is −1.16 K%. See more stats in MEDIVIR AB financial statements.
Like other stocks, MVIR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIVIR AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIVIR AB technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIVIR AB stock shows the sell signal. See more of MEDIVIR AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.